Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am

Insight into the treatment of Metastatic Pancreatic/intestine/ovarian Cancer: MiRNA-206 suppresses the expression of PDGF Receptor β via down regulation of its target gene., 5/June/2014, 5.03 am
June 4, 2014
Pathologic insights into the regulation of Muscle wasting and atrophy: BMP4 increases the expression of eIF4E3 via down regulation of its target gene, 5/June/2014, 5.49 am
June 5, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Antimetastatic therapy for Liver cancer: Metformin, the widely used drug to treat NIDDM, inhibits metastatic hepatocellular carcinoma through up regulation of its target gene USP9X, 5/June/2014, 5.38 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.